AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Kenvue Inc. operates as a consumer health company worldwide.
The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health.
The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands.
The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names.
The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands.
The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.
Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Country | United States |
IPO Date | May 4, 2023 |
Industry | Household & Personal Products |
Sector | Consumer Defensive |
Employees | 22,000 |
CEO | Thibaut Mongon |
Contact Details
Address: 199 Grandview Road Skillman, New Jersey United States | |
Website | https://www.kenvue.com |
Stock Details
Ticker Symbol | KVUE |
Exchange | NYSE |
Fiscal Year | February - January |
Reporting Currency | USD |
CIK Code | 0001944048 |
CUSIP Number | 49177J102 |
ISIN Number | US49177J1025 |
Employer ID | 88-1032011 |
SIC Code | 2844 |
Key Executives
Name | Position |
---|---|
Thibaut Mongon | Chief Executive Officer & Director |
Paul Ruh | Chief Financial Officer |
Bernardo Tavares | Chief Data & Technology Officer |
Carlton Lawson | Group President of EMEA & Latin America |
Dr. Caroline Tillett Ph.D. | Chief Scientific Officer |
Ellie Bing Xie | Group President of Asia Pacific |
Heather R. Howlett | Chief Accounting Officer |
Matthew Orlando | General Counsel |
Meredith Stevens | Chief Operations Officer |
Tina Romani | Head of Investor Relations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 13, 2024 | 4 | Filing |
Dec 13, 2024 | 4 | Filing |
Dec 13, 2024 | 4 | Filing |
Dec 03, 2024 | 4 | Filing |
Dec 03, 2024 | 4 | Filing |
Dec 03, 2024 | 4 | Filing |
Dec 03, 2024 | 4 | Filing |
Dec 03, 2024 | 4 | Filing |
Dec 03, 2024 | 4 | Filing |
Dec 03, 2024 | 4 | Filing |